Tourmaline Bio, Inc.

Q2 2025 13F Holders

Symbol
TRML
CUSIP
89157D105
Type
Equity
Class
COM
Num filings
4
Total reported value, excl. options
$449 k
Manager Report Date Value ($000) Shares Option Type